submit to the journals

Cardiovascular Risk Journal Articles, Videos And Insights

Cardiovascular Risk:FEATURED Articles

flipper_slider

Cardiovascular Risk: Latest Articles

Cardiovascular Risk: INSIGHTS

The touchENDOCRINOLOGY website provides a selection of resources to inform clinicians and patients about the latest developments in the field. The following are quick, non peer-reviewed, opinion-based updates addressing current trends and opinion on the most recent advances in the area of endocrinology:

Insight
Lipodystrophy – an Insight into a Rare Condition with Severe Metabolic Consequences Katrina Mountfort, Senior Medical Writer, Touch Medical Media, UK
Matthew Goodwin, Group Director and Advisory Editor, Touch Medical Media, UK
-Insights into lipodystrophies, presented at the ECE congress, Barcelona, Spain, Monday 21 May 2018

Cardiovascular Risk:FEATURED VIDEOS

Editor's choice

Jeffrey S Elmendorf discusses the impact of cholesterol in type 2 diabetes and the latest findings from current studies. Questions: 1. Why is cholesterol of interest for metabolic health and disease? (0:07) 2. Is cellular cholesterol toxicity and type 2 diabetes risk supported by clinical findings? (0:50) 3. Are there data that explain the incidence of increased type 2 diabetes risk with statin therapy? (1:27) 4. How does pitavastatin differ in having a favorable impact on metabolic health? (3:18) View the full article here. Speaker disclosures: Jeffrey S Elmendorf has nothing to declare in relation to this video interview. Support: The publication of this video was supported by Kowa Pharmaceuticals America who was given the opportunity to review the video for scientific accuracy before publication. Any resulting changes were made at the author’s/authors’ discretion.
BREAKING NEWS: Oral medications can help people with type 2 diabetes reach their blood glucose targets. But there has been a cloud of suspicion over new diabetes drugs and whether they may increase the risk for cardiovascular and other problems. Today we heard the results of studies that looked at two types of these medications. Rhonda Anderson reports from Boston.

Cardiovascular Risk:Latest Videos

Video List based on Category on Node Page

Latest Videos

Jeffrey S Elmendorf discusses the impact of cholesterol in type 2 diabetes and the latest findings from current studies. Questions: 1. Why is cholesterol of interest for metabolic health and disease? (0:07) 2. Is cellular cholesterol toxicity and type 2 diabetes risk supported by clinical...
Professor Holst discusses his current research and the most important current findings in diabetes. Questions 1. In today’s post-genomic era, are there any major endocrine hormones similar to GLP-1 left to discover? (0:12) 2. Will ‘diet pills’ will ever be able to outperform lifestyle...
Professor Rutten gives his perspective on the latest developments in safe de-intensification in the elderly. Questions 1. What are the latest developments in safe de-intensification in the elderly? (0:12) 2. What is your current research focus? (2:06) 3. What have been your highlights of...
Dr Raza discusses the current status of aspirin use and the latest clinical trial data. Questions: 1. What is the historic importance of aspirin use? (0:12) 2. What are the current practices and guidelines for aspirin use? (1:00) 3. What recent data have been presented in aspirin use?...
During EASD 2018 in Berlin, Dr Joshi discusses his poster presented at the congress: the results from 4-year DiaCRE study, which estimated cardiovascular risk in Indian type 2 diabetic patients. Questions: 1. Tell us some more about your poster presented at this year’s EASD (0:12) 2. What...
We are pleased to introduce Abd Tahrani as the new Editor in Chief for European Endocrinology. In this interview Dr Tahrani discusses his research interests and his aims for the journal over the next year. FILMED AT THE EUROPEAN ASSOCIATION FOR THE STUDY OF DIABETES (EASD) ANNUAL MEETING,...

LATEST TWEETS

Conference Highlights